Cargando…
S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428503/ http://dx.doi.org/10.1097/01.HS9.0000967740.44843.f0 |
| _version_ | 1785090485707079680 |
|---|---|
| author | Wang, Xiaoli Hu, Cing Siang Davis, Andrew Krejsa, Cecile Hoffman, Ronald |
| author_facet | Wang, Xiaoli Hu, Cing Siang Davis, Andrew Krejsa, Cecile Hoffman, Ronald |
| author_sort | Wang, Xiaoli |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428503 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104285032023-08-17 S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL Wang, Xiaoli Hu, Cing Siang Davis, Andrew Krejsa, Cecile Hoffman, Ronald Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428503/ http://dx.doi.org/10.1097/01.HS9.0000967740.44843.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Wang, Xiaoli Hu, Cing Siang Davis, Andrew Krejsa, Cecile Hoffman, Ronald S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title | S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title_full | S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title_fullStr | S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title_full_unstemmed | S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title_short | S207: NAVTEMADLIN, AN ORAL MDM2 INHIBITOR, ELIMINATES MYELOPROLIFERATIVE NEOPLASM-BLAST PHASE (MPN-BP) INITIATING CELLS AND PROLONGS LEUKEMIA-FREE SURVIVAL (LFS) IN AN MPN-BP PDX MODEL |
| title_sort | s207: navtemadlin, an oral mdm2 inhibitor, eliminates myeloproliferative neoplasm-blast phase (mpn-bp) initiating cells and prolongs leukemia-free survival (lfs) in an mpn-bp pdx model |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428503/ http://dx.doi.org/10.1097/01.HS9.0000967740.44843.f0 |
| work_keys_str_mv | AT wangxiaoli s207navtemadlinanoralmdm2inhibitoreliminatesmyeloproliferativeneoplasmblastphasempnbpinitiatingcellsandprolongsleukemiafreesurvivallfsinanmpnbppdxmodel AT hucingsiang s207navtemadlinanoralmdm2inhibitoreliminatesmyeloproliferativeneoplasmblastphasempnbpinitiatingcellsandprolongsleukemiafreesurvivallfsinanmpnbppdxmodel AT davisandrew s207navtemadlinanoralmdm2inhibitoreliminatesmyeloproliferativeneoplasmblastphasempnbpinitiatingcellsandprolongsleukemiafreesurvivallfsinanmpnbppdxmodel AT krejsacecile s207navtemadlinanoralmdm2inhibitoreliminatesmyeloproliferativeneoplasmblastphasempnbpinitiatingcellsandprolongsleukemiafreesurvivallfsinanmpnbppdxmodel AT hoffmanronald s207navtemadlinanoralmdm2inhibitoreliminatesmyeloproliferativeneoplasmblastphasempnbpinitiatingcellsandprolongsleukemiafreesurvivallfsinanmpnbppdxmodel |